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the negative impact of laws regarding biosecurity and bioter-
rorism on real diseases. As the article states, ‘The actual
number of known victims and fatalities caused by the intentional
use of microorganisms has been negligible as compared with
those caused by naturally acquired human infections.’ This is
indeed true of Bacillus anthracis, with anthrax infection most
commonly community acquired than associated with bioter-
rorism. It seems prudent, therefore, to understand how this
disease naturally presents. For instance, a new form of cuta-
neous anthrax has been recently recognized in injecting drug
users and named injectional anthrax. We present three cases of
injectional anthrax that offer a unique insight into the rare
entity B. anthracis meningitis.
Meningitis due to infection with B. anthracis is considered a
rare manifestation of anthrax, with just over 100 reported cases
in the world literature, but it is associated with high mortality,
as it is nearly always fatal [2]. Also, injectional anthrax can be a
challenge for clinicians to recognize as a result of its unfamiliar
and atypical presentation. The typical sign of cutaneous
anthrax—a black-crusted painless lesion, known as an
eschar— is not normally found [3]. An outbreak of injectional
anthrax occurred in injection drug users in Scotland during
2009–2010 that was linked to the use of contaminated heroin
[4]. Out of 119 cases, 47 were laboratory conﬁrmed, and 13 of
these conﬁrmed cases were fatal [3]. Three cases of death were
attributed to anthrax meningitis at postmortem examination,Clinical Microbiology and Infection © 2015 European Society of Cthus certifying the ﬁrst case collection of anthrax meningitis
during an injectional anthrax outbreak.
All three patients presented with severe illness and neuro-
logic symptoms. Case 1 occurred in a 34-year-old male injecting
heroin user, who presented with a 36-hour history of severe
headache, confusion and agitation. Examination revealed evi-
dence of injecting drug use; however, no infection at the in-
jection sites was identiﬁed. At admission, he developed a
generalized tonic-clonic seizure, and intravenous ceftriaxone
was initiated for suspected meningitis. Head computed to-
mography (CT) revealed extensive subarachnoid blood (Fig. 1)
with a small occipital haemorrhage. His condition rapidly
deteriorated, and he was anaesthetized and intubated before
being transferred to the intensive care unit. He died within 12
hours of admission. Diagnosis after postmortem examination
was injectional anthrax meningitis with numerous Gram-
positive rods in brain tissue, and brain and spleen tissue were
both PCR positive for B. anthracis.
The second case occurred in a 55-year-old male injecting
heroin user, who presented with seizure and collapse. Exami-
nation revealed marked erythema and oedema to his right arm
and axilla with evidence of injecting drug use noted on this arm.
He was treated with ﬂucloxacillin for soft tissue infection. The
patient’s condition deteriorated, and neurologically, he devel-
oped reduced tone on his left side, positive Babinski sign and
Glasgow Coma Scale score of 8/15. CT revealed extensive
subarachnoid blood within the cerebral sulci and interhemi-
spheric ﬁssure with small subcortical haemorrhages in the right
frontal lobe and left parietal lobe (Fig. 1). He died within 24
hours of admission. Cultures of blood samples drawn at
admission were positive for B. anthracis after 48 hours. Post-
mortem external examination revealed severe swelling of the
entire right arm with a small area of haemorrhage within the
skin of the forearm and a small blister which was not typical of
an anthrax eschar. Blood PCR was positive for B. anthracis.
Blood was also anti–protective antigen (PA) IgG positive and
anti– lethal factor (LF) IgG equivocal on serology and immu-
noreactive PA and LF positive. Medical cause of death was
septicaemia and haemorrhagic meningitis as a result of cuta-
neous anthrax.
The third case occurred in a 41-year-old male heroin user
(injection and inhalation) who presented with a 48- to 72-hour
history of confusion, lethargy and feeling generally unwell. Ex-
amination revealed mottling and injecting drug use but no evi-
dence of infection. After a rapid deterioration in his level of
consciousness and hemodynamic instability, he was transferred
to the intensive care unit for mechanical ventilation and ino-
trope therapy. His head CT revealed extensive subarachnoidClin Microbiol Infect 2015; 21: e49–e50
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.cmi.2015.05.023
FIG. 1. Unenhanced axial CT. Head appearances of three cases of B. anthracis meningitis. (A) Case 1, extensive subarachnoid blood is present with
small occipital haemorrhage. There is also effacement of lateral and third ventricles and slightly reduced attenuation of white matter indicative of early
cerebral oedema. (B) Case 2, extensive subarachnoid blood within cerebral sulci and interhemispheric ﬁssure with small subcortical haemorrhages in
right frontal lobe and left parietal lobe. (C) Case 3, extensive subarachnoid blood within supra- and infratentorial cerebrospinal ﬂuid spaces, and small
cerebral haemorrhage with adjacent oedema in left frontal lobe.
e50 Clinical Microbiology and Infection, Volume 21 Number 8, August 2015 CMIblood within the supra- and infratentorial cerebrospinal ﬂuid
spaces, and a small cerebral haemorrhage with adjacent oedema
in the left frontal lobe (Fig. 1). As anthrax meningitis was sus-
pected. Intravenous benzylpenicillin, clindamycin and cipro-
ﬂoxacin were started as per Health Protection Scotland
guidelines (http://www.documents.hps.scot.nhs.uk/giz/anthrax-
outbreak/clinical-guidance-for-use-of-anthrax-immune-globulin-
v12-1-2010-03-19.pdf). Blood cultures ﬂagged positive for
B. anthracis less than 24 hours after incubation. Blood was
positive for B. anthracis on PCR and was also immunoreactive
PA and LF positive. Endotracheal aspirate was positive for
B. anthracis on PCR. Anthrax immunoglobulin was arranged to
be given, but the patient’s condition rapidly deteriorated. He
developed multiorgan failure and died within 48 hours of
admission. After death, because the case had been presented as
a conﬁrmed case of systemic anthrax, the body was not
transported from the place of death and was not physically
examined. Death was attributed to septicaemia and haemor-
rhagic meningitis due to probable inhalation anthrax.
In conclusion, by examining these cases of anthrax menin-
gitis, we provide new insight into community-acquired injec-
tional anthrax infection—community-acquired infection being a
far more common presentation of anthrax that that associated
with bioterrorism [1]. As is the case in our patients, anthrax
meningitis is a rapidly progressive illness with severe neurologic
sequelae. Indeed, it was only in one of our cases that theClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectworking diagnosis of anthrax meningitis was made while the
patient was still alive. However, all cases had antemortem CT
evidence of subarachnoid haemorrhage, and a suspicion of
anthrax meningitis would thus have been justiﬁed. The early
recognition and suspicion of anthrax meningitis should occur in
all cases of systemic anthrax, especially with evidence of sub-
arachnoid blood on CT scan and because microbiology results
can be delayed.Transparency declarationAll authors report no conﬂicts of interest relevant to this letter.References[1] Wurtz N, Grobusch MP, Raoult D. Negative impact of laws regarding
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